Servicio de Microbiología Clínica y Enfermedades Infecciosas del Hospital General Universitario Gregorio Marañón, Universidad Complutense. CIBERES. Ciber de Enfermedades Respiratorias. Madrid, Spain.
Rev Esp Quimioter. 2022 Apr;35(2):115-130. doi: 10.37201/req/158.2021. Epub 2021 Dec 11.
The precocity and efficacy of the vaccines developed so far against COVID-19 has been the most significant and saving advance against the pandemic. The development of vaccines has not prevented, during the whole period of the pandemic, the constant search for therapeutic medicines, both among existing drugs with different indications and in the development of new drugs. The Scientific Committee of the COVID-19 of the Illustrious College of Physicians of Madrid wanted to offer an early, simplified and critical approach to these new drugs, to new developments in immunotherapy and to what has been learned from the immune response modulators already known and which have proven effective against the virus, in order to help understand the current situation.
到目前为止，针对 COVID-19 开发的疫苗的早熟性和疗效是对抗大流行的最重要和最具挽救性的进展。在整个大流行期间，疫苗的开发并没有阻止人们不断地寻找治疗药物，包括具有不同适应症的现有药物和新药物的开发。马德里杰出医师学院 COVID-19 科学委员会希望对这些新药、免疫疗法的新进展以及从已经了解的、对病毒有效的免疫调节剂的免疫反应调节剂中吸取的经验教训进行早期、简化和批判性的探讨，以帮助理解当前的情况。
